Voyage Biomedical logo — Developing a medical device to reduce brain damage from isch...

Voyage Biomedical

Developing a medical device to reduce brain damage from ischemic events

Founded 2018 United States San Francisco, United States 1 employees Pre-Seed Total: $150.00K Health Care

General Information

Company Name Voyage Biomedical
Founded Year 2018
Location United States San Francisco, United States
Employees 1
Industries Health Care
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Voyage Biomedical. To contact Voyage Biomedical, visit voyage.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Voyage Biomedical compare?

A PDF of Voyage Biomedical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Voyage Biomedical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Voyage Biomedical

Voyage Biomedical is a promising startup with a clear focus on revolutionizing the treatment of cardiac arrests. The company is developing a medical device aimed at reducing brain damage from ischemic events, which has the potential to be a game-changer in the field. Affiliated with UCSF and UC Berkeley, Voyage Biomedical benefits from strong partnerships with reputable institutions. Based in the United States, it has positioned itself in a hub of innovation and healthcare excellence. While specific details about their last investment are not available, the company's dedication to addressing a critical medical need and its strategic partnerships make it a compelling investment opportunity for venture capitalists.

Business keywords: medical device, brain damage, ischemic events, central venous line, cardiac arrest, UCSF, UC Berkeley, treatment revolution, biomedical engineering, neuroprotection, startup, research collaboration, medical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $150.00K 3
Berkeley SkyDeck, Y Combinator +1
20 Apr 2019

Voyage Biomedical Alternatives & Competitors

View All Alternatives
Voyage Biomedical vs
NeuroSave, Inc.
NeuroSave, Inc. United States

NeuroSave is a clinical-stage medical device company dedicated to preventing and treating ischemic b...

Debt Financing
1 employees
Health Care
Voyage Biomedical vs
EpiHeart
EpiHeart Finland

Enabling new cardiac treatments

5 employees
Health Care, Manufacturing
Voyage Biomedical vs

Evanesc Therapeutics is revolutionizing the treatment of neurological diseases with their patented E...

3 employees
Health Care

FAQ About Voyage Biomedical

Developing a medical device to reduce brain damage from ischemic events
Voyage Biomedical was founded in 2018.
Voyage Biomedical is headquartered in San Francisco, United States.
Voyage Biomedical operates in Health Care. Its work centres on medical device, brain damage, ischemic events and central venous line.
Voyage Biomedical has approximately 1 employees.
Voyage Biomedical has completed 1 funding round, raising a total of $150.00K. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Voyage Biomedical include NeuroSave, Inc., EpiHeart, Evanesc Therapeutics, Thubrikar Aortic Valve, Carthera. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Voyage Biomedical and NeuroSave, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Voyage Biomedical, https://bouncewatch.com/company/voyage-biomedical, updated 11 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes